Financial reports
Current reports
8-K
Completion of Acquisition or Disposition of Assets
24 Feb 23
8-K
Regulation FD Disclosure
21 Feb 23
8-K
CinCor Pharma to be Acquired by AstraZeneca
9 Jan 23
8-K
Regulation FD Disclosure
28 Nov 22
8-K
Regulation FD Disclosure
8 Nov 22
8-K
CinCor Pharma Appoints Michael W. Kalb, Executive Vice President and Chief Financial Officer
7 Nov 22
8-K/A
Results of Operations and Financial Condition
4 Nov 22
8-K
CinCor Reports Third Quarter Financial Results and Provides Corporate Update
3 Nov 22
8-K
CinCor Pharma Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
11 Aug 22
8-K
CinCor Reports Second Quarter Financial Results and Provides Corporate Update
8 Aug 22
Registration and prospectus
15-12G
Securities registration termination
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Feb 23
25-NSE
Exchange delisting
24 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
24 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
24 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
23 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
15 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
13 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
3 Feb 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
11 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
1 Aug 22
EFFECT
Notice of effectiveness
7 Jan 22
SEC STAFF
SEC staff action: Order
7 Jan 22
CERT
Certification of approval for exchange listing
5 Jan 22
CORRESP
Correspondence with SEC
4 Jan 22
CORRESP
Correspondence with SEC
4 Jan 22
SEC STAFF
SEC staff action: Order
21 Dec 21
Ownership
SC 13D/A
Sofinnova Capital IX
3 Mar 23
SC 13D/A
Sofinnova Venture Partners X, L.P.
1 Mar 23
SC 13D/A
5AM Ventures VI, L.P.
28 Feb 23
4
Andrew J. Schwab
28 Feb 23
SC 13D/A
GENERAL ATLANTIC, L.P.
28 Feb 23
4
JAMES HEALY
27 Feb 23
4
Mason Freeman
27 Feb 23
4
David D. Allison
24 Feb 23
4
Troy A. Ignelzi
24 Feb 23
4
Michael Wayne Kalb
24 Feb 23